mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase

J Allergy Clin Immunol Pract. 2022 Jan;10(1):322-325. doi: 10.1016/j.jaip.2021.09.051. Epub 2021 Oct 20.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asparaginase
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Hypersensitivity, Immediate*
  • Polyethylene Glycols
  • RNA, Messenger
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • Polyethylene Glycols
  • pegaspargase
  • Asparaginase